Nascent Biotech (NBIO) Stock Overview

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

NBIO Stock Information

Symbol

NBIO

Address

631 US Hwy 1North Palm Beach, FL 33408United States

Founded

Trading hours

Website

https://www.nascentbiotech.com

Country

🇺🇸 United States

Phone Number

612 961 5656

Nascent Biotech (NBIO) Price Chart

Nascent Biotech Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.0465	N/A
Market Cap	$5.51M	N/A
Shares Outstanding	118.57M	10.05%
Employees	0	N/A
Shareholder Equity	-1.30M	93.03%

Valuation	2023	Change
P/E Ratio	-2.32	N/A
P/B Ratio	-4.25	N/A

Growth	2023	Change
Return on Equity	2.1610	N/A

Earnings	2023	Change
Revenue	$0	N/A
Earnings	-$2.80M	N/A
EPS	-0.02	N/A
Earnings Yield	-0.4301	N/A

Financial Strength	2023	Change
Total Assets	$255.00K	N/A
Cash on Hand	$172.19K	N/A
Debt to Equity	-1.1967	3.44%
Current Ratio	0.1644	21.16%